José Juan Verocay was born on June 16, 1876 in Paysandú, Uruguay to Italian immigrants; in 1887 they sent him to Cortina d'Ampezzo to learn languages first; he then graduated from the high school in Trento (1897) and from the German Medical Faculty in Prague (1904) where he, a disciple of Hanns Chiari, became the 1st demonstrator (1902), 3rd (1904) to 1st assistant (1905), and volunteer (from 1908) at the Department of Pathological Anatomy. He repeatedly substituted the professors Chiari (until 1906), Kretz (1907-1910), and Ghon (from 1910) during their absence. Anomalies and neoplasms prevailed among his research subjects. In the paper "Zur Kenntnis der »Neurofibrome«" (1910) he introduced the term "neurinoma" for a tumor with characteristic structures later named "Verocay bodies". On the basis of the paper he was habilitated for pathological anatomy as private docent at the German Medical Faculty in Prague (1911). During World War I he served for the Austro-Hungarian army at military hospitals in Chrudim (Bohemia) and Vienna. After the war he returned to Uruguay to work as a general practitioner in his native region (1919-1921), thereafter in Montevideo as head of pathological laboratories at the military hospital (1921-1925), at the Dental School (1925-1927), and at the Medical Faculty Department of Neurology (from March 19, 1927). As early as on May 3, 1927, however, he had to retire due to rapid worsening of his pulmonary tuberculosis. The renowned scientist remained a stranger in his own country ("el patólogo de Praga"); he never gained professorship except for a symbolic proclamation by devoted students on August 24, 1927, two days before he left for Europe to undergo treatment. On December 26, 1927 he died in Dubí (a spa near Teplice in Bohemia, Czechoslovakia, now Czech Republic).
Download full-text PDF |
Source |
---|
BMC Health Serv Res
January 2025
Department of Biological Sciences, Faculty of Science, Kyambogo University, Kampala, Uganda.
Background: A key concern for global public health is nosocomial infections. Essential to the fight against nosocomial infection, is healthcare professionals' knowledge and attitudes. Therefore, this study investigated healthcare professionals' knowledge and attitudes toward nosocomial infection at the Kiruddu Referral Hospital, Kampala, Uganda.
View Article and Find Full Text PDFBMC Health Serv Res
January 2025
Department of Social Welfare Management, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Objectives: Rehabilitation services are crucial for improving the quality of life and overall health of individuals with spinal cord injuries (SCIs). However, access to adequate rehabilitation remains limited in many regions, including Iran. This study aims to explore the barriers faced by individuals with SCIs in accessing appropriate rehabilitation services within Golestan province, northern of Iran.
View Article and Find Full Text PDFInfect Agent Cancer
January 2025
Shahid Beheshti University of Medical Sciences, Hamadan University of Medical Sciences, Hamadan, Iran.
Both women and men are now confronted with the grave threat of cancers caused by the human papillomavirus (HPV). It is estimated that 80% of women may encounter HPV over their lives. In the preponderance of cases involving anal, head and neck, oral, oropharyngeal, penile, vaginal, vulvar, and cervical malignancies, high-risk HPV (HR-HPV) is the causative agent.
View Article and Find Full Text PDFBMC Res Notes
January 2025
Laboratory of Health and Life Science, Graduate School of Health and Sports Science, Juntendo University, Inzai, 270-1695, Japan.
Objective: Dictyostelium differentiation-inducing factors 1 and 3 [DIF-1 (1) and DIF-3 (2), respectively], along with their derivatives, such as Ph-DIF-1 (3) and Bu-DIF-3 (4), demonstrate antibacterial activity in vitro against Gram-positive bacteria, including methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant S. aureus (MRSA), vancomycin-sensitive Enterococcus faecalis (VSE), and vancomycin-resistant Enterococcus faecium [VRE (VanA)]. This study investigates the therapeutic potential of DIF compounds against these Gram-positive bacteria.
View Article and Find Full Text PDFBMC Med
January 2025
Department of Public Health Sciences, Stockholm University, Stockholm, Sweden.
Background: Many studies have found more severe COVID-19 outcomes in migrants and ethnic minorities throughout the COVID-19 pandemic, while recent evidence also suggests higher risk of longer-term consequences. We studied the risk of a long COVID diagnosis among adult residents in Sweden, dependent on country of birth and accounting for known risk factors for long COVID.
Methods: We used linked Swedish administrative registers between March 1, 2020 and April 1, 2023, to estimate the risk of a long COVID diagnosis in the adult population that had a confirmed COVID-19 infection.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!